{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:41Z","timestamp":1787496881738,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1331\/japha.2014.13106","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T15:45:35Z","timestamp":1389282335000},"page":"69-73","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacist initiation of postexposure doxycycline for Lyme disease prophylaxis"],"prefix":"10.1016","volume":"54","author":[{"given":"Anita N.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kelly Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Bratberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Silverblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2014.13106_bb0010","unstructured":"Centers for Disease Control and Prevention. Lyme disease transmission. www.cdc.gov\/lyme\/transmission\/index.html. Accessed May 11, 2013."},{"issue":"10","key":"10.1331\/JAPhA.2014.13106_bb0015","first-page":"1","article-title":"Surveillance for Lyme disease: United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"10.1331\/JAPhA.2014.13106_bb0020","unstructured":"Centers for Disease Control and Prevention. Lyme disease data. www.cdc.gov\/lyme\/stats\/index.html. Accessed May 11, 2013."},{"issue":"7","key":"10.1331\/JAPhA.2014.13106_bb0025","first-page":"208","article-title":"Introduction: Lyme disease","volume":"91","author":"Larkin","year":"2008","journal-title":"Medicine Health Rhode Island"},{"key":"10.1331\/JAPhA.2014.13106_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IDR.S15653","article-title":"Lyme disease: the next decade","volume":"4","author":"Stricker","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1331\/JAPhA.2014.13106_bb0035","unstructured":"Centers for Disease Control and Prevention. Post-treatment Lyme disease syndrome. www.cdc.gov\/lyme\/postLDS\/index.html. Accessed May 11, 2013."},{"issue":"2","key":"10.1331\/JAPhA.2014.13106_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"Nadelman","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1331\/JAPhA.2014.13106_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jac\/dkq097","article-title":"Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis","volume":"65","author":"Warshafsky","year":"2010","journal-title":"J Antimicrob Chemo"},{"issue":"9","key":"10.1331\/JAPhA.2014.13106_bb0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1331\/JAPhA.2014.13106_bb0055","unstructured":"University of Rhode Island Tick Encounter Resource Center. Frequently asked questions: tickborne disease. www.tickencounter.org\/faq\/tick_borne_disease. Accessed July 31, 2013."},{"key":"10.1331\/JAPhA.2014.13106_bb0060","unstructured":"Centers for Disease Control and Prevention. Lyme disease: a public information guide. www.cdc.gov\/lyme\/resources\/brochure\/508_LD_Brochure.pdf. Accessed May 11, 2013."},{"key":"10.1331\/JAPhA.2014.13106_bb0065","unstructured":"Centers for Disease Control and Prevention. Ticks and Lyme disease. www.cdc.gov\/lyme\/resources\/toolkit\/factsheets\/10_508_Lyme%20disease_HikersCampers_FACTSheet.pdf. Accessed May 11, 2013."},{"issue":"5","key":"10.1331\/JAPhA.2014.13106_bb0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amepre.2005.08.003","article-title":"Statewide impact of pharmacist-delivered adult influenza vaccinations","volume":"29","author":"Bearden","year":"2005","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1331\/JAPhA.2014.13106_bb0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2003.08.045","article-title":"The role of pharmacists in the delivery of influenza vaccinations","volume":"22","author":"Steyer","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1331\/JAPhA.2014.13106_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.293.1.54","article-title":"Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial","volume":"293","author":"Raine","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1331\/JAPhA.2014.13106_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1345\/aph.1L556","article-title":"Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation","volume":"43","author":"Dent","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1331\/JAPhA.2014.13106_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1331\/JAPhA.2010.09199","article-title":"Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign","volume":"50","author":"Potter","year":"2010","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1331\/JAPhA.2014.13106_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2146\/ajhp050543","article-title":"Effect of pharmacist-led patient education on adherence to tuberculosis treatment","volume":"64","author":"Clark","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"45","key":"10.1331\/JAPhA.2014.13106_bb0100","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2011.08.051","article-title":"Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations","volume":"29","author":"Taitel","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1331\/JAPhA.2014.13106_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2307\/2673721","article-title":"Increasing access to emergency contraception through community pharmacies: lessons from Washington State","volume":"33","author":"Gardner","year":"2001","journal-title":"Fam Plann Perspect"},{"issue":"1","key":"10.1331\/JAPhA.2014.13106_bb0110","first-page":"67","article-title":"Medication therapy management and collaborative drug therapy management","volume":"16","author":"Roberst","year":"2010","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"10.1331\/JAPhA.2014.13106_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1331\/JAPhA.2008.07138","article-title":"Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study","volume":"48","author":"Gardner","year":"2008","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/JAPhA.2014.13106_bb0120","unstructured":"Northwest Center for Public Health Practice. Collaborative drug therapy agreement for influenza antivirals in Washington State. www.nwcphp.org\/training\/opportunities\/toolkits-guides\/collaborative-drug-therapy-agreement-for-influenza-antivirals-in-washington-state. Accessed May 11, 2013."},{"key":"10.1331\/JAPhA.2014.13106_bb0125","unstructured":"Redlich GS. R.I.\u2019s Good Samaritan Law offers protection: up to a point. http:\/\/block-island.villagesoup.com\/p\/r-i-s-good-samaritan-law-offers-protection-up-to-a-point\/1002266#. Accessed May 24, 2013."},{"key":"10.1331\/JAPhA.2014.13106_bb0130","unstructured":"SteelFisher G, Koonin LM, Rothholz MC, Patel A. New approaches during a pandemic for antiviral medication dispensing: collaboration that utilizes the community pharmacist [webinar]. http:\/\/elearning.pharmacist.com\/products\/1111\/new-approaches-during-a-pandemic-for-antiviral-medication-dispensing-collaboration-that-utilizes-the-community-pharmacist. Accessed May 24, 2013."}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115301400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115301400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T08:20:53Z","timestamp":1538900453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115301400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1544319115301400"],"URL":"https:\/\/doi.org\/10.1331\/japha.2014.13106","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}